Semiconductors & Related Devices
OSI Systems, Inc. designs and manufactures electronic systems and components worldwide. It operates in three segments: Security, Healthcare, and Optoelectronics and Manufacturing. The Security segment offers baggage and parcel inspection, cargo and vehicle inspection, hold baggage and people screening, radiation detection, and explosive and narcotics trace detection systems under the Rapiscan Systems, AS&E, and Gatekeeper names. It also provides site design, installation, training, and technical support services; and security screening solutions under the S2 name. The Healthcare segment offers patient monitoring and diagnostic cardiology systems, and related supplies and accessories under the Spacelabs name for use in critical care, emergency, and perioperative areas within hospitals, physicians' offices, medical clinics, and ambulatory surgery centers. The Optoelectronics and Manufacturing segment provides optoelectronic devices under the OSI Optoelectronics, OSI LaserDiode, OSI Laserscan, Semicoa, and Advanced Photonix names for the aerospace and defense, avionics, medical imaging and diagnostics, biochemistry analysis, pharmaceutical, nanotechnology, telecommunications, construction, and homeland security markets. It also offers electronics manufacturing services to original equipment manufacturers and end users for medical, automotive, defense, aerospace, industrial, and consumer applications under the OSI Electronics, APlus Products, Altaflex, and PFC names; and LCD displays for medical, industrial, and consumer electronics applications, as well as flex circuits for OEM customers. This segment offers laser-based remote sensing devices to detect and classify vehicles in toll and traffic management systems under the OSI Laserscan and Autosense names; and solid-state laser products for aerospace, defense, telecommunication, and medical applications under the OSI LaserDiode name. The company was incorporated in 1987 and is headquartered in Hawthorne, California.
Sector
In the chart Earnings are multiplied by this value.
High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.
Years | 06-2015 | 06-2016 | 06-2017 | 06-2018 | 06-2019 | 06-2020 | 06-2021 | 06-2022 | 06-2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|
Net Margin | 6.8% | 3.2% | 2.2% | -2.7% | 5.5% | 6.5% | 6.5% | 9.7% | 7.2% | 8.6% |
ROA | 9.4% | 3.9% | 2.7% | 4.5% | 8.5% | 8.3% | 8.3% | 9.7% | 8.7% | 10% |
ROE | 11% | 4.8% | 3.7% | -6% | 12% | 13% | 12% | 18% | 13% | 15% |
The average Net Margin over the past 5 years is +5.44%.
The trend of Net Margin over the past 5 years is +1.77%.
The average ROA over the past 5 years is +8%.
The trend of ROA over the past 5 years is +0.71%.
The average ROE over the past 5 years is +10.2%.
The trend of ROE over the past 5 years is +3.15%.
Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.
Years | 06-2015 | 06-2016 | 06-2017 | 06-2018 | 06-2019 | 06-2020 | 06-2021 | 06-2022 | 06-2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|
Debt FCF | 0.16 | 0.28 | 5.40 | 3.26 | 2.83 | 2.47 | 2.26 | 11.15 | 1.95 | -2.60 |
Debt Equity | 0.02 | 0.02 | 0.43 | 0.60 | 0.47 | 0.47 | 0.43 | 0.84 | 0.21 | 0.17 |
MIN | ||||||||||
Graham Stability | - | - | 45% | -78% | 100% | 100% | 100% | 100% | 100% | -78% |
The Debt/FCF trailing twelve month is -2.60.
The trend of Debt/FCF over the past 5 years is 0.52.
Graham’s Stability measure stands at -0.78.
Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.
Years | 06-2016 | 06-2018 | 06-2020 | 06-2022 | Trend |
---|---|---|---|---|---|
Revenue | 6.4% | 3.3% | 3.1% | 8% | 0.16% |
Net Income | 20% | - | 6.8% | -20% | 2.9% |
Stockholders Equity | 4.3% | 8.2% | 8.3% | 14% | 1.2% |
FCF | 9.5% | -2.7% | -10% | 62% | 1.3% |
The Revenue CAGR over the past 5 years is +3.25%.
The trend of Revenue growth rate over the past 5 years is +0.16%.
The Earnings CAGR over the past 5 years is -.
The trend of Earnings growth rate over the past 5 years is +2.92%.
The Equity CAGR over the past 5 years is +8.21%.
The trend of Equity growth rate over the past 5 years is +1.15%.
The FCF CAGR over the past 5 years is -2.71%.
The trend of FCF growth rate over the past 5 years is +1.25%.